Skip to main content
. 2021 May 13;8:101383. doi: 10.1016/j.mex.2021.101383

Fig. 1.

Fig 1

DYRK1A TR-FRET tracer optimization and determination of assay window. A. Tracer optimization: optimal assay window (11.5) with Tracer concentration at 18 nM. B. Dose response curves to determine assay window. Dasatinib included as negative control.